The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2010
DOI: 10.1016/j.nano.2009.11.006
|View full text |Cite
|
Sign up to set email alerts
|

Release dynamics of ciprofloxacin from swellable nanocarriers of poly(2-hydroxyethyl methacrylate): an in vitro study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
22
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 73 publications
(22 citation statements)
references
References 21 publications
0
22
0
Order By: Relevance
“…Several CFX delivery systems have been developed for the treatment of specific infections such as microspheres, multilamellar liposomes, hydrogels, scaffolds, implants membranes, polymer blends or nanoparticles (Aranaz et al, 2009;Budai, 2007;Cho, 2003;Chouhan & Bajpai, 2010;Dias Murbach et al, 2014;DiTizio, 1998;Koort et al, 2008;Ogawa & Plepis, 2002;Venkatasubbu, Ramasamy, Ramakrishnan, & Kumar, 2011;Verma, Bansal, Gosh, & Pandit, 2012;Wang, Dong, Du,& Kennedy, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Several CFX delivery systems have been developed for the treatment of specific infections such as microspheres, multilamellar liposomes, hydrogels, scaffolds, implants membranes, polymer blends or nanoparticles (Aranaz et al, 2009;Budai, 2007;Cho, 2003;Chouhan & Bajpai, 2010;Dias Murbach et al, 2014;DiTizio, 1998;Koort et al, 2008;Ogawa & Plepis, 2002;Venkatasubbu, Ramasamy, Ramakrishnan, & Kumar, 2011;Verma, Bansal, Gosh, & Pandit, 2012;Wang, Dong, Du,& Kennedy, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…However, particles above approximately 200 nm must have some kind of deformability in order to avoid deposition in the spleen, were fenestrations typically are 200-500 nm in width [11]. These considerations, combined with the effects of the particle size and compactness on drug release rates [12][13][14], highlight the importance of estimating both the size and the compactness (or deformability) of nanoparticulate drug delivery systems. However, in contrast to the particle size, the particle compactness is seldom reported.…”
Section: Introductionmentioning
confidence: 99%
“…CFX suffers from moderate oral bioavailability [23], as it chelates with calcium-, magnesium- and aluminium-containing salts upon concomitant administration [24]. In drug delivery systems, CFX has been used with various drug carriers such as polymeric nanoparticles [25-27], cyclodextrin [28], chitosan [29], montmorillonite [30] and calcium apatite [31]. …”
Section: Introductionmentioning
confidence: 99%